<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">53244</article-id><article-id pub-id-type="doi">10.7554/eLife.53244</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-164925"><name><surname>Murata</surname><given-names>Kenji</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-164926"><name><surname>Nakatsugawa</surname><given-names>Munehide</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-164927"><name><surname>Rahman</surname><given-names>Muhammed A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-164928"><name><surname>Nguyen</surname><given-names>Linh T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164929"><name><surname>Millar</surname><given-names>Douglas G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-99076"><name><surname>Mulder</surname><given-names>David Thomas</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164930"><name><surname>Sugata</surname><given-names>Kenji</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164931"><name><surname>Saijo</surname><given-names>Hiroshi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164932"><name><surname>Matsunaga</surname><given-names>Yukiko</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164933"><name><surname>Kagoya</surname><given-names>Yuki</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164934"><name><surname>Guo</surname><given-names>Tingxi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50929"><name><surname>Anczurowski</surname><given-names>Mark</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164935"><name><surname>Wang</surname><given-names>Chung-Hsi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-176125"><name><surname>Burt</surname><given-names>Brian D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-176126"><name><surname>Ly</surname><given-names>Dalam</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164936"><name><surname>Saso</surname><given-names>Kayoko</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-164937"><name><surname>Easson</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164938"><name><surname>Goldstein</surname><given-names>David P</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164943"><name><surname>Reedijk</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164940"><name><surname>Ghazarian</surname><given-names>Danny A</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117401"><name><surname>Pugh</surname><given-names>Trevor J</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50932"><name><surname>Butler</surname><given-names>Marcus O</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-176127"><name><surname>Mak</surname><given-names>Tak W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-164941"><name><surname>Ohashi</surname><given-names>Pamela S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-49492"><name><surname>Hirano</surname><given-names>Naoto</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9070-4754</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf7"/></contrib><aff id="aff1"><institution content-type="dept">Princess Margaret Cancer Centre</institution>, <institution>University Health Network</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff2"><institution content-type="dept">Clinical Cancer Genomics</institution>, <institution>University Health Network</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff3"><institution content-type="dept">Department of Immunology</institution>, <institution>University of Toronto</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff4"><institution content-type="dept">Surgical Oncology</institution>, <institution>University Health Network</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff5"><institution content-type="dept">Laboratory Medicine and Pathobiology</institution>, <institution>University Health Network</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff6"><institution content-type="dept">Medical Biophysics</institution>, <institution>University of Toronto</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-10828"><name><surname>Kroemer</surname><given-names>Guido</given-names></name><role>Reviewing editor</role><aff><institution>University of Paris Descartes</institution>, <country>France</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>naoto.hirano@uhnresearch.ca</email> (NH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>04</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e53244</elocation-id><history><date date-type="received"><day>01</day><month>11</month><year>2019</year></date><date date-type="accepted"><day>04</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Murata et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Murata et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-53244-v1.pdf"/><abstract><p>HLA-restricted T cell responses can induce antitumor effects in cancer patients. Previous human T cell research has largely focused on the few HLA alleles prevalent in a subset of ethnic groups. Here, using a panel of newly developed peptide-exchangeable peptide/HLA multimers and artificial antigen-presenting cells for 25 different class I alleles and greater than 800 peptides, we systematically and comprehensively mapped shared antigenic epitopes recognized by tumor-infiltrating T lymphocytes (TILs) from eight melanoma patients for all their class I alleles. We were able to determine the specificity, on average, of 12.2% of the TILs recognizing a mean of 3.1 shared antigen-derived epitopes across HLA-A, B, and C. Furthermore, we isolated a number of cognate T cell receptor genes with tumor reactivity. Our novel strategy allows for a more complete examination of the immune response and development of novel cancer immunotherapy not limited by HLA allele prevalence or tumor mutation burden.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004203</institution-id><institution>Ontario Institute for Cancer Research</institution></institution-wrap></funding-source><award-id>Clinical Investigator Award,IA-039</award-id><principal-award-recipient><name><surname>Hirano</surname><given-names>Naoto</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Province of Ontario</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Anczurowski</surname><given-names>Mark</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000038</institution-id><institution>Natural Sciences and Engineering Research Council of Canada</institution></institution-wrap></funding-source><award-id>Postgraduate Scholarship</award-id><principal-award-recipient><name><surname>Guo</surname><given-names>Tingxi</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004376</institution-id><institution>Terry Fox Research Institute</institution></institution-wrap></funding-source><award-id>Immunotherapy NeTwork (iTNT) Program</award-id><principal-award-recipient><name><surname>Hirano</surname><given-names>Naoto</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004376</institution-id><institution>Terry Fox Research Institute</institution></institution-wrap></funding-source><award-id>Immunotherapy NeTwork (iTNT) Program</award-id><principal-award-recipient><name><surname>Ohashi</surname><given-names>Pamela S</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Princess Margaret Cancer Centre Innovattion Accelerator Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hirano</surname><given-names>Naoto</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009812</institution-id><institution>Princess Margaret Cancer Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hirano</surname><given-names>Naoto</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009812</institution-id><institution>Princess Margaret Cancer Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Butler</surname><given-names>Marcus O</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004489</institution-id><institution>Mitacs</institution></institution-wrap></funding-source><award-id>Intership</award-id><principal-award-recipient><name><surname>Murata</surname><given-names>Kenji</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Postdoctoral Fellowship for Overseas Researchers and a Guglietti Fellowship</award-id><principal-award-recipient><name><surname>Kagoya</surname><given-names>Yuki</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution>Province of Ontario</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Guo</surname><given-names>Tingxi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Kenji Murata, The University Health Network has filed patent application related to this study on which Kenji Murata is named as an inventor (US16/095,913, US62/813,639, US62/813,642, US62/813,644, US62/813,645, US62/813,647, US62/813,650, US62/813,651, and US62/823,487)..</p></fn><fn fn-type="conflict" id="conf3"><p>Munehide Nakatsugawa, The University Health Network has filed patent application related to this study on which Munehide Nakatsugawa is named as an inventor (US16/095,913)..</p></fn><fn fn-type="conflict" id="conf4"><p>Muhammed A Rahman, The University Health Network has filed patent application related to this study on which Muhammed A. Rahman is named as an inventor (US16/095,913)..</p></fn><fn fn-type="conflict" id="conf5"><p>Kayoko Saso, The University Health Network has filed patent application related to this study on which Kayoko Saso is named as an inventor (US62/813,639, US62/813,642, US62/813,644, US62/813,645, US62/813,647, US62/813,650, US62/813,651, and US62/823,487)..</p></fn><fn fn-type="conflict" id="conf6"><p>Marcus O Butler, Marcus O. Butler has served on advisory boards for Merck, BMS, Novartis, GSK, Immunocore, immunovaccine, Sanofi, and EMD Serono and received research funding for investigator initiated clinical trials from Merck and Takara Bio..</p></fn><fn fn-type="conflict" id="conf7"><p>Naoto Hirano, Naoto Hirano reports receiving a research grant from and is a consultant for Takara Bio and Otsuka Pharmaceutical and serving on an advisory board for F. Hoffmann-La Roche. The University Health Network has filed patent application related to this study on which Naoto Hirano is named as an inventor (US16/095,913, US62/813,639, US62/813,642, US62/813,644, US62/813,645, US62/813,647, US62/813,650, US62/813,651, and US62/823,487)..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This study was conducted in accordance with the Helsinki Declaration and approved by the Research Ethics Board of the University Health Network, Toronto, Canada (UHN REB# 11-0343, 11-0348).  Written informed consent was obtained from all healthy donors who provided peripheral blood samples.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-53244-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>